Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

Background: PET scans using FDG and somatostatin receptor imaging agents have both been used to study neuroendocrine tumours. Most reports have documented the sensitivity and specificity of each radiopharmaceutical independently, and even suggested the superiority of one over the other for different...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, David LH, Pavlakis, Nick, Schembri, Geoffrey P, Bernard, Elizabeth J, Hsiao, Edward, Hayes, Aimee, Barnes, Tristan, Diakos, Connie, Khasraw, Mustafa, Samra, Jaswinder, Eslick, Enid, Roach, Paul J, Engel, Alexander, Clarke, Stephen J, Bailey, Dale L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399582/
https://www.ncbi.nlm.nih.gov/pubmed/28435454
http://dx.doi.org/10.7150/thno.18068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399582/
https://www.ncbi.nlm.nih.gov/pubmed/28435454
http://dx.doi.org/10.7150/thno.18068

Ejemplares similares